Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF – Get Free Report) shares traded up 8.4% on Thursday . The company traded as high as $12.25 and last traded at $12.25. 2,000 shares changed hands during mid-day trading, a decline of 65% from the average session volume of 5,785 shares. The stock had previously closed at $11.30.
Surgical Science Sweden AB (publ) Price Performance
The company’s fifty day moving average price is $12.05 and its two-hundred day moving average price is $13.10.
Surgical Science Sweden AB (publ) Company Profile
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases.
Featured Stories
- Five stocks we like better than Surgical Science Sweden AB (publ)
- What is a SEC Filing?
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- Buy P&G Now, Before It Sets A New All-Time High
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Receive News & Ratings for Surgical Science Sweden AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgical Science Sweden AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.